Related by context. All words. (Click for frequent words.) 51 clinical 50 budesonide MMX Phase III 49 Syndax Pharmaceuticals Inc. 48 data management Clintrial 48 including eniluracil ADH 48 clincial 47 recombinant PSMA vaccine 47 GRN# 46 CRLX# 46 IIa clinical trials 46 aesthetic dermatological conditions 46 stage hypoxia activated 45 LibiGel ® Phase III 45 ENDEAVOR IV 45 mecarbil 45 BioSante LibiGel Phase III 45 EDEMA3 trial 44 Dr Gillian Braunold 44 randomized Phase IIb 44 pivotal bioequivalence 44 trastuzumab DM1 T DM1 44 IIa clinical 44 Neurostep TM 43 CYT# potent vascular disrupting 43 OvaRex 43 TBC# 43 phase IIb 43 BRIM3 43 perfusion CT 43 Clinical 43 unblinding 43 Corlux 42 Lauren Silvernail 42 leading oral taxane 42 phase IIb III 42 novel therapeutic antibodies 42 PORxin TM platforms 42 INS# [001] 42 Phase IIIb study 42 Urocortin 2 42 ABSORB trial 42 Facet Solutions 42 ONCONASE R 42 intravenous methylnaltrexone 42 eTag assays 42 clinically 42 GEM OS2 42 phase IIa clinical 42 Phase Ib study 42 Novolimus 42 TRIST study 42 Phase IIIB IV 42 GLPG# 41 biomarker identification 41 ReN# 41 Ceflatonin 41 Acute Coronary Syndromes ACS 41 orally inhaled migraine 41 Zenvia ™ 41 pharmacokinetic PK study 41 endocrinology oncology 41 investigational HCV polymerase 41 Acute Decompensated Heart Failure 41 CHAMPION PCI 41 cangrelor 41 recurrent herpes labialis 41 thorough QT 41 JAK2 inhibitor 41 radiolabeled TM# 41 midstage clinical 41 Phase IIb III 41 Phase IIb clinical trials 41 BLA filing 41 tumor immunology 41 www.nextrials.com 41 clinicial 41 optimal dosing regimens 41 CINQUIL 41 PEARL SC 41 phase IIa 41 International Nasdaq PRAI 41 OvaRex R 41 Phase Ib II 41 clinical trials 41 OncoVEX 41 dexanabinol 41 blood clot dissolver 40 GCP compliant 40 Phase 1b trial 40 prospective longitudinal 40 p# inhibitor 40 severe hypercholesterolemia 40 Trofex 40 therapeutic monoclonal antibody 40 midstage trials 40 Archexin 40 Proellex TM 40 PRIMO CABG 40 Aethlon Hemopurifier R 40 Plicera 40 rALLy 40 vemurafenib 40 CA9 SCAN 40 Zoraxel 40 SPARLON 40 Factor VIIa 40 immatics 40 Voraxaze ™ 40 PICSO ® 40 phase IIb study 40 DXL# 40 IL# PE#QQR 40 clinical trial 40 Phase IIIb clinical 40 fidaxomicin Phase 3 40 IND enabling 40 oral talactoferrin 40 EmbraceAC 40 phase IIIb 40 clinical pharmacology studies 40 BRAF inhibitor 40 OPTTX 40 AA Amyloidosis 40 MAXY alpha 40 predictive biomarkers 40 multicenter Phase II 40 HuMax EGFr 40 vivo preclinical 40 indicates cardio circulatory 40 BioMAP 40 Inc. Nasdaq NLTX 40 galiximab 40 RE LY 40 ospemifene 40 EGS# 39 alvespimycin 39 FOLOTYN ® 39 Androxal TM 39 oral ridaforolimus 39 clevidipine 39 urology oncology 39 IMC #B 39 GEM OS1 39 CR# vcMMAE 39 MAXY VII 39 GSK# [002] 39 CytoFab ™ 39 GLP toxicology studies 39 Hedgehog inhibitor 39 Cloretazine R 39 Prodarsan R 39 DFCI 39 safinamide 39 tiapamil 39 Xcytrin R 39 radezolid 39 SUTENT ® 39 TACI Ig 39 rALLy trial 39 HGS# 39 gynecologic procedures 39 NTDDS platform 39 PD2i Analyzer 39 oral methylnaltrexone 39 Phase 1a clinical 39 Cogane 39 fostamatinib 39 preclinical pharmacology 39 almorexant 39 SILENOR 39 elotuzumab 39 subcutaneous immunoglobulin 39 haematological cancers 39 Mipomersen 39 BR.# 39 DDP# 39 oral PTH 39 invasive candidiasis 39 balsalazide tablet 39 Capesaris 39 preclinically 39 elagolix 39 anidulafungin 39 recurrent glioma 39 EC Cysteamine 39 translational medicine 39 molecular oncology 39 Nonclinical 39 Cancidas 39 kidney urologic 39 Proxinium TM 39 ALN HTT 39 candidate CRLX# 39 Phase 2b clinical 39 lenalidomide Revlimid R 39 everolimus eluting stents 39 tolevamer 39 immunotherapeutic vaccine 39 pertuzumab 39 Cloretazine ® 39 microplasmin Phase III 39 SUCCEED trial 39 PDE4 inhibitor 39 ALN PCS 39 Aethlon Hemopurifier ® 39 Phase IIa trial 39 DPX Survivac 39 alemtuzumab MS 39 forodesine 38 Phase Ib clinical 38 catheter occlusion 38 Cethromycin 38 Fx #A 38 Vasogen Celacade TM 38 Prostate Px + 38 investigational therapies 38 genomic biomarker 38 TKM ApoB 38 CARE HF 38 EP #R 38 RSD# oral 38 nonclinical studies 38 Alequel 38 selective androgen receptor modulator 38 Prodarsan ® 38 Phase IIb trial 38 preclinical efficacy 38 NeuroFlo 38 HCD# [002] 38 GAMMAGARD 38 OncoVEX GM CSF 38 novel oral anticoagulant 38 MAGE A3 ASCI 38 Rasagiline 38 bosutinib 38 oral prodrug 38 Actilon 38 phase IIb clinical 38 CCR9 antagonist 38 GGF2 38 Aryplase 38 tezampanel NGX# 38 Zybrestat 38 prelicensure 38 VITAL Trial 38 postoperative ileus POI 38 TLK# 38 rALLy clinical trial 38 Puricase PEG uricase 38 CB2 selective receptor agonist 38 INFUSE ® 38 radiographic outcomes 38 Hedgehog agonist 38 bardoxolone methyl 38 neratinib 38 dextofisopam 38 UltiMAb ® 38 QTinno TM 38 MYDICAR 38 biased ligand 38 ophthalmology dermatology cardiovascular disease 38 prospective multicenter 38 vivo pharmacology 38 BioLife enabling 38 double blinded randomized 38 biostatistical 38 VTE prevention 38 RhuDex 38 gefitinib Iressa 38 AFRS TM 38 Phase III clinical trials 38 Phase IIB 38 Phase IIb clinical 38 Ceflatonin R 38 CCX# 38 lomitapide 38 Phase IIb 38 Virulizin ® 38 isavuconazole 38 Surfaxin LS 38 PANVAC VF 38 vinca alkaloid 38 placebo controlled clinical 38 clinicaltrials 37 diabetic neuropathic pain 37 Myocet 37 DAPT 37 Cloretazine R VNP#M 37 clazosentan 37 ELACYT 37 Phase IIa clinical 37 liprotamase 37 Phase #b/#a 37 IMA# 37 OLYMPIA registry 37 Adlea TM 37 Prednisporin TM 37 budesonide foam 37 biliary tract cancer 37 IIa trial 37 Neo Kidney Augment 37 IND submission 37 Desmoteplase 37 Removab 37 Alocrest 37 TKM PLK1 37 fosbretabulin 37 PROSTVAC TM 37 Phase #/#a 37 EDEMA3 37 Val HeFT 37 abstracts summarizing 37 elacytarabine 37 Ophena 37 Phase 2b study 37 NovaBay Aganocide compounds 37 molecular profiling 37 CURE AF 37 Rheos System 37 Vicinium TM 37 ZFP Therapeutic 37 pharmacologic treatments 37 Dalbavancin 37 Phase #b/#a trial 37 HORIZONS AMI 37 pharmacogenetics 37 preclinical pharmacokinetic 37 bicifadine 37 NP2 Enkephalin 37 pain palliation 37 pharmacokinetic pharmacodynamic 37 pivotal Phase III 37 preclinical toxicology 37 velafermin 37 Pharma Medica 37 OHR/AVR# 37 Proxinium 37 OnDose TM 37 Stimuvax R 37 renal anemia 37 PsychoGenics 37 sodium thiosulfate STS 37 MabThera rituximab 37 BACcel 37 Vascular Wrap 37 targeted radiotherapeutic 37 Fabry Disease 37 FFR measurement 37 Glybera R 37 cannabinor 37 neuroimmunology 37 AVADO 37 INOmax R 37 prospective nonrandomized 37 postapproval 37 CLARITY study 37 Adlea 37 AERx iDMS 37 micafungin 37 AMPAKINE CX# 37 GI motility disorders 37 Clinical Trials 37 Altrazeal TM Silver 37 ticagrelor Brilinta 37 pharmacogenomic testing 37 Cx# [002] 37 Annamycin 37 TNFerade TM 37 CRMD# 37 molecular pathology 37 rindopepimut 37 MyVax ® 37 PDE# inhibitors 37 clinical pharmacology 37 Sigma Tau SpA 37 Simulect 37 psychometrically sound 37 Exherin TM 37 Ereska 37 Hepatocellular Carcinoma HCC 37 TriGrid 36 MEND CABG II 36 prospective multicenter study 36 intranasal insulin 36 Celator 36 confirmatory clinical 36 JAK2 inhibitors 36 Manja Bouman CEO 36 intravenous acetaminophen 36 OZURDEX ® 36 Meta analyzes 36 Memryte 36 Panzem R NCD 36 PHX# 36 tezampanel 36 rxRNA 36 ancrod 36 Ketotransdel 36 REALITY Trial 36 NTDDS 36 epigenetic therapies 36 phase IIb trial 36 Elocalcitol 36 AQUAVAN R 36 PREGNANT Study 36 neurology cardiology 36 ataluren 36 Phase Ib IIa clinical 36 Durata 36 Dataflow Manager 36 ALTROPANE 36 Lixivaptan 36 UltiMAb R technology 36 ESBA# 36 trastuzumab DM1 36 oncology dermatology 36 clinicians 36 INxin TM 36 antiangiogenic agents 36 XL# SAR# 36 multicenter clinical trials 36 XmAb 36 Phase III clinical 36 SinuNase TM 36 Tovaxin ® 36 davunetide intranasal AL 36 LibiGel ® 36 PRECISE trial 36 ColorectAlert TM 36 Oral NKTR 36 Phase IIa trials 36 peri operative 36 PMA submission 36 QLT# 36 Wellstat 36 R#/MEM # 36 ADAGIO study 36 EchoCRT 36 ProTrials Research 36 incyclinide 36 JAK inhibitor 36 ASONEP 36 visilizumab 36 lintuzumab 36 atherosclerosis regression 36 tasimelteon 36 Aurexis 36 thetreatment 36 postmarket safety 36 XP #L 36 luliconazole 36 Nanobody ® 36 Gag polymorphisms 36 DermTech International 36 eprotirome 36 confirmatory Phase III 36 celgosivir 36 enzastaurin 36 phase III ACCLAIM 36 RelayHealth securely processes 36 Valdoxan 36 omacetaxine 36 rBChE 36 COMFORT II 36 Phase III trials 36 OvaRex MAb 36 oral antiviral 36 RESOLUTE clinical 36 CAPHOSOL 36 BrachySil TM 36 Quinamed 36 aerosolized KL4 surfactant 35 randomized blinded 35 deforolimus 35 dirucotide 35 teriflunomide 35 rt PA 35 Nanobody 35 ProSavin 35 plaque excision 35 BEMA TM Fentanyl 35 Dacogen injection 35 IRX 2 35 metastatic sarcomas 35 Fibrin Pad 35 Metricath Gemini 35 Genasense ® 35 faropenem 35 RGB # 35 Sequenom CMM 35 viral kinetic 35 Mepact 35 predictive toxicology 35 Phase 1b clinical 35 GLP toxicology 35 FavId 35 MOZOBIL 35 riociguat 35 zileuton CR 35 Instanyl 35 daptomycin 35 CBLC# 35 subcutaneous formulation 35 HeFH 35 INTERCEPT platelets 35 REG1 35 TRO# 35 Tectin TM 35 Tarek Sherif CEO 35 Edwards SAPIEN valve 35 fibrin sealant 35 rEEG 35 MEND CABG 35 FFR measurements 35 personalized cellular immunotherapy 35 Electronic Brachytherapy 35 cystinosis patients 35 Phase III randomized controlled 35 LibiGel Phase III 35 zanolimumab 35 SNT MC# 35 Allovectin 7 35 recombinant factor VIIa 35 cytopathology 35 Phase 2a clinical trials 35 hematologic oncology 35 constipation OIC 35 acute ischemic stroke 35 molecular imaging radiopharmaceutical 35 Azedra TM 35 farletuzumab 35 cGMP manufacture 35 vernakalant hydrochloride 35 inhalation toxicology 35 rHuPH# 35 Q#IR 35 eniluracil 35 pediatric intensivists 35 ALN TTR# 35 TELINTRA 35 mechanical thrombectomy 35 NEXTERONE 35 Phase IIb trials 35 Phase III VISTA 35 Phase Ib 35 PD2i ® 35 Phase 1b 35 Triapine R 35 ruxolitinib 35 MGd 35 oral taxane 35 lumiliximab 35 Bioaccelerate compounds under 35 Zevalin consolidation 35 candidates Dyloject TM 35 AZX# 35 cerebral oximetry 35 Phase 2b clinical trials 35 Kendle NASDAQ KNDL 35 clinical informatics 35 Amigal 35 ATIR TM 35 Sudhir Agrawal D.Phil 35 reslizumab 35 ORENCIA R 35 topically applied SEPA 35 EECP ® therapy 35 sunitinib malate 35 Neuradiab 35 cancer immunotherapies 35 candidate TNFerade biologic 35 eosinophilic asthma 35 rhC1INH 35 Posidur 35 Bicifadine 35 procedural sedation 35 YONDELIS 35 interventional neuroradiology 34 metabolite identification 34 Aplidin 34 solid organ transplantation 34 REVEAL Registry 34 treating neuropathic pain 34 Zavesca r 34 adipose derived stem cell 34 patient 34 interventional pulmonology 34 evaluating Nexavar 34 TQT studies 34 Phase III TRIST 34 POSIDUR TM 34 REMINYL ® 34 GeneSightRx 34 Zemiva TM 34 FVIIa 34 immunological diseases 34 efficacy tolerability 34 M6G 34 Onalta 34 human microdosing 34 Vilazodone 34 Ophena TM 34 rheumatologic 34 HQK 34 Perforomist ™ Inhalation Solution 34 Hemopurifier 34 tonabersat 34 adipiplon 34 Zavesca R 34 lorvotuzumab mertansine 34 eculizumab therapy 34 intranasal formulation 34 Intarcia 34 antithrombotic therapy 34 IV acetaminophen 34 tubulin inhibitor 34 Numoda 34 pharmacoeconomic 34 ChronVac C R 34 Phase 2a clinical 34 Nanobodies ® 34 HGS ETR1 34 IIa trials 34 QOPI 34 RE COVER 34 SJTRI 34 lexidronam injection 34 metaanalysis 34 LEUKINE 34 BEXXAR 34 cartilage regeneration 34 PREOS 34 Nivestim 34 SEPET TM 34 systemic RNAi 34 patients 34 oral RSD# 34 Cethrin 34 CytoFabTM 34 interventional therapies 34 PK PD modeling 34 pharmacodynamic properties 34 ADVANCE PD 34 AERx 34 COU AA 34 Liprotamase 34 IMPROVE HF 34 Prednisporin 34 VEGF Trap 34 NSABP 34 Phase Ia 34 pharmacogenetic testing 34 RE LY ® 34 talactoferrin 34 INCB# [001] 34 Catabasis 34 Nasulin 34 Phase IIa 34 anti angiogenic agents 34 teduglutide 34 Zenvia Phase III 34 bioequivalency 34 pharmacology 34 retrospective observational study 34 haematologic 34 HORIZONS AMI trial 34 Clonicel 34 punctal plug drug 34 bardoxolone 34 OMAPRO 34 kinase profiling 34 Zingo TM 34 oxymorphone ER 34 NATRECOR ® 34 pharmacotherapeutic 33 hematological malignancy 33 Firazyr ® 33 preclinical 33 Azedra 33 Hedgehog antagonist 33 ASCEND HF 33 guideline concordant 33 injectable formulations 33 briakinumab 33 Accelovance 33 CB1 antagonists 33 StemEx R 33 registrational 33 pharmacoepidemiology 33 Vascular Wrap TM 33 coronary intervention 33 gastroenterological 33 opioid induced bowel dysfunction 33 Targeted Chemotherapy 33 SYNTAX trial 33 phase Ib 33 gepirone ER 33 pharmacokinetic PK 33 R#/MEM 33 PREOS R 33 Icatibant 33 ostarine 33 microRNA profiling 33 Cloretazine 33 translational research 33 canakinumab 33 Cardio Vascu Grow 33 non alcoholic steatohepatitis 33 angiographic outcomes 33 EECP R 33 Referenced EEG 33 EECP ® 33 KuDOS 33 Celacade TM 33 placebo controlled Phase III 33 CoFactor 33 BNC# 33 ACRIN 33 PRT# 33 ALGRX 33 BST CarGel R 33 ENMD # 33 MYCAMINE 33 pharmacogenetic tests 33 Aganocide 33 PK PD 33 clinically relevant 33 therapeutic regimens 33 psychiatry neurology 33 MERLIN TIMI 33 Sernova Cell Pouch 33 AZILECT ® 33 Cellegesic 33 Pyridorin 33 psychopharmacological 33 multicenter trials 33 Zemplar Capsules 33 ganetespib 33 Altastaph 33 Aurora kinase inhibitors 33 Phase 2b trial 33 Dynogen 33 transplantation immunology 33 dermaPACE TM 33 methylnaltrexone 33 clinically validated 33 CIP ISOTRETINOIN 33 XmAb ® 33 cardiometabolic 33 gastroenterology 33 anticoagulation 33 Renal Cell Carcinoma RCC 33 temsirolimus Torisel ® 33 AeroLEF TM 33 EndoTAG TM 33 Phase IIIb 33 NEUMUNE 33 rFactor XIII 33 HERmark assay 33 opioid induced constipation 33 sulodexide 33 EOquin 33 daclizumab 33 viral kinetics 33 Neuradiab TM 33 pharmacokinetic 33 PSN# [002] 33 immunology 33 alvimopan 33 pediatric bipolar disorder 33 Phase 2a trial 33 Neovasc Reducer 32 palifosfamide 32 PLK1 SNALP 32 acute decompensated heart 32 biomarker discovery 32 pharmacotherapies 32 diagnostic 32 Vion Pharmaceuticals 32 Rezular 32 KineMed 32 YONDELIS R 32 tafamidis 32 TOCOSOL Paclitaxel 32 CIPN 32 HCV polymerase inhibitor 32 oncology cardiology 32 Toraymyxin TM 32 CDRD 32 isoform selective 32 ACTILON 32 Squalamine 32 Rhucin R 32 Clinical Research 32 oncologic 32 Pervasis 32 Xanodyne 32 Glenveigh 32 postmarket surveillance 32 maribavir 32 personalized immunotherapy 32 Sunrise Ambulatory Care 32 preclinical studies 32 KRN# 32 punctal plug delivery 32 Panzem R 32 Avastin adjuvant 32 oxypurinol 32 pediatric rheumatology 32 randomized trials 32 CINTREDEKIN BESUDOTOX 32 AcelRx 32 Fentanyl TAIFUN R 32 renin inhibition 32 torezolid phosphate 32 herpetic keratitis 32 senicapoc 32 tipranavir 32 sacral nerve stimulation 32 favorable pharmacokinetic profile 32 Clinical Trial 32 pediatric 32 Oasmia 32 CaPre TM 32 Jean Pierre Sommadossi Ph.D. 32 ularitide 32 COR Analyzer 32 obatoclax 32 dirucotide MBP# 32 null responder 32 Itopride 32 tecarfarin 32 Evoltra ® 32 blinded randomized controlled 32 EGEN 32 MyVax personalized immunotherapy 32 TMS Therapy 32 Aerosurf 32 cardio renal 32 Exelixis compounds 32 OvaRex ® MAb 31 RIGScan CR 31 interventional cardiac 31 resuscitative measures 31 RhuDex ® 31 opioid analgesia 31 GED aPC 31 external counterpulsation systems 31 NTx ® -# 31 Ketotransdel TM 31 noninfectious uveitis 31 pharmacogenetic 31 vidofludimus 31 Sulonex 31 pharmacological therapies 31 ICA # 31 omecamtiv mecarbil 31 BETAS 31 torcetrapib atorvastatin 31 AspenBio 31 oncology 31 aripiprazole Abilify 31 TRV# [001] 31 Periowave TM Photodisinfection System 31 Huntexil 31 ZEVALIN ® 31 HspE7 31 entinostat 31 randomized clinical trials 31 PFO migraine 31 Entereg R 31 CardioFit 31 TYZEKA 31 MGN# 31 KL4 surfactant 31 Viprinex 31 bioanalysis 31 LymphoStat B 31 Fibrocaps 31 UPLYSO 31 Stedivaze 31 oncology virology 31 Cutanea 31 Plenaxis TM 31 huN# DM1 31 dacetuzumab 31 hematology microbiology 31 QTinno 31 interprofessional education 31 ViaCyte 31 neurosurgical 31 Solazed 31 bioabsorbable stent 31 HealthCore 31 Soliris TM eculizumab 30 EXPAREL 30 Tolerx 30 THALOMID 30 RELOVAIR ™ 30 Serdaxin 30 relapsed multiple myeloma 30 cardiothoracic surgical 30 PEG PAL 30 HIV integrase inhibitors 30 companion diagnostics 30 CLORETAZINE TM VNP#M 30 oncology neurology 30 nonclinical 30 pharmaco 30 Veronate 30 vilazodone 30 Intraject 30 analgesic efficacy 30 BioDisc 30 PORxin TM 30 non nucleoside 30 Kendle Nasdaq KNDL 30 ADME 30 Cortex AMPAKINE 30 pharmacogenomics 30 Lymphoseek ® 30 revision hip arthroplasty 30 EOquin TM 30 clinically meaningful 30 tremelimumab 30 diagnostic prognostic 30 therapeutics 30 refractory angina 30 therapeutic armamentarium 30 Preclinical 30 Altrazeal ® 30 OXi# 30 prostone 30 NEUGENE antisense 30 GI endoscopy 30 AzaSite Plus 30 postoperative ileus 29 postmarketing surveillance 29 perinatal 29 therapeutic antibody 29 ganaxolone 29 clinician 29 eTag assay 29 Hyphanox 29 Medifacts 29 pharmacodynamic PD 29 Sulonex TM 29 investigational 29 AQ4N 29 schizophrenia CIAS 29 Combo Stent 29 pharmacokinetic studies 29 AssureRx 29 Chrysalin 29 OraTest R 29 cardiotoxic effects 29 crofelemer 29 pharmacoeconomics 29 Neo Kidney Augment ™ 28 Opexa 28 REMOXY ® 28 AVN# [001] 28 biomarker 28 Cleviprex TM clevidipine 28 Tragara Pharmaceuticals Inc. 28 tolerability profiles 28 tolerability 28 Med eMonitor System 28 ePRO 28 convenient dosing regimen 28 nicotinic alpha 7 27 OFIRMEV 27 Mpex 27 pharmacologic 27 invivodata 27 B. Lynne Parshall 27 HEOR 26 Medidata Rave 26 prehospital 26 bioanalytical laboratories 26 perioperative 26 renal 26 ToleroMune 26 inVentiv Clinical 26 ophthalmology 26 vosaroxin 26 physicians 26 therapeutic 25 eRT 25 Personalized Oncology 25 pharmacodynamic 24 pharmacovigilance 24 ACORN CRO 24 efficacy 24 biologic 24 CellerateRx 24 Referenced EEG ® 23 biologics 22 dermatologic